FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPES
代谢型谷氨酸受体亚型的功能
基本信息
- 批准号:2269298
- 负责人:
- 金额:$ 13.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 1996-07-31
- 项目状态:已结题
- 来源:
- 关键词:CHO cells adenylate cyclase antireceptor antibody dentate gyrus entorhinal cortex enzyme activity epitope mapping excitatory aminoacid glutamate receptor granule cell immunocytochemistry interneurons isoproterenol laboratory rabbit laboratory rat lipolysis membrane potentials neural inhibition neurotransmitter transport oligopeptides phosphatidylcholines synapses voltage /patch clamp
项目摘要
The hippocampus plays an important role in a number of normal
physiological processes and in pathological conditions, including
Alzheimer's disease and epilepsy. Development of a complete understanding
of the molecular and cellular mechanisms of regulation of synaptic
function in the hippocampus could lead to new Strategies for treatment
of these disorders. Until recently, it was thought that most neuro-
modulatory influences on hippocampal function required activation of
extrinsic afferents and that all of the actions of glutamate, the major
neurotransmitter intrinsic to the hippocampus, were mediated by
activation of ligandgated cation channels. However, it is now clear that
glutamate also activates receptors, known as metabotropic glutamate
receptors (mGluRs), that are coupled to effector systems through GTP
binding proteins. To date, 5 mGluR subtypes have been cloned. However,
the precise roles of the different mGluR subtypes in regulating neuronal
excitability and synaptic transmission in the hippocampus are not known.
A complete understanding of both normal and pathological hippocampal
function will require a detailed understanding of the roles of mGluRs in
regulating hippocampal physiology. Interestingly, application of IS,3R-
ACPD (a selective mGluR agonist) to hippocampal slices, potentiates
cyclic AMP responses to agonists of other receptors that are positively
coupled to adenylate cyclase. Also, IS,3R-ACPD has a number of important
physiological effects in the hippocampus. These include, among others,
a decrease in synaptic -inhibition in hippocampal area CA1 and a decrease
in evoked population spikes in the dentate gyrus. However, the precise
cellular and synaptic mechanisms by which mGluR agonists modulate
inhibitory and excitatory synaptic responses in the hippocampus are not
known. Furthermore, the physiological relevance of 1S,3R-ACPD-induced
potentiation of cyclic AMP responses is not known. A series of
experiments is proposed in which microelectrode and patch clamp
recordings from hippocampal neurons will be used to test the hypothesis
that 1S,3R-ACPD decreases synaptic inhibition in area CA1 and evoked
population spikes in dentate gyrus by reducing excitatory transmission
onto inhibitory interneurons and dentate granule cells, respectively.
Also, experiments will be performed to determine the physiological role
of mGluR-mediated potentiation of cyclic AMP responses in regulating
synaptic transmission in the hippocampus. Finally, specific antibodies
will be raised against each of the cloned mGluR subtypes. These will be
used to determine the precise cellular and subcellular localization of
the different mGluR subtypes in the hippocampal formation. These
studies, coupled with the electrophysiological experiments, will provide
valuable information regarding the roles of specific mGluR subtypes in
regulating hippocampal function.
海马体在许多正常生理活动中发挥着重要作用
生理过程和病理条件,包括
阿尔茨海默病和癫痫症。形成完整的理解
突触调节的分子和细胞机制
海马体的功能可能会带来新的治疗策略
这些疾病。 直到最近,人们还认为大多数神经
对海马功能的调节影响需要激活
外在传入和谷氨酸的所有作用,主要
海马体固有的神经递质,由
配体门控阳离子通道的激活。 然而,现在很清楚的是
谷氨酸还激活受体,称为代谢型谷氨酸
受体 (mGluR),通过 GTP 与效应系统耦合
结合蛋白。迄今为止,已克隆了 5 个 mGluR 亚型。然而,
不同 mGluR 亚型在调节神经元中的精确作用
海马体的兴奋性和突触传递尚不清楚。
对正常和病理海马的完整了解
功能需要详细了解 mGluRs 在
调节海马生理。有趣的是,IS,3R-的应用
ACPD(一种选择性 mGluR 激动剂)作用于海马切片,增强
环AMP对其他受体激动剂的反应呈阳性
与腺苷酸环化酶偶联。此外,IS,3R-ACPD 有许多重要的
海马体的生理效应。其中包括,除其他外,
海马 CA1 区突触抑制减少
齿状回的诱发群体峰值。然而,准确的
mGluR 激动剂调节的细胞和突触机制
海马体的抑制性和兴奋性突触反应不
已知。此外,1S,3R-ACPD 诱导的生理相关性
环 AMP 反应的增强作用尚不清楚。一系列
提出了实验,其中微电极和膜片钳
海马神经元的记录将用于检验假设
1S,3R-ACPD 降低 CA1 区突触抑制并诱发
通过减少兴奋性传递,齿状回的数量激增
分别作用于抑制性中间神经元和齿状颗粒细胞。
此外,还将进行实验以确定其生理作用
mGluR介导的环AMP反应增强在调节中的作用
海马体中的突触传递。 最后是特异性抗体
将针对每个克隆的 mGluR 亚型产生。这些将是
用于确定精确的细胞和亚细胞定位
海马结构中不同的 mGluR 亚型。 这些
研究与电生理学实验相结合,将提供
有关特定 mGluR 亚型在
调节海马功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
P Jeffrey Conn其他文献
Promise of mGluR2/3 activators in psychiatry
mGluR2/3 激活剂在精神病学中的前景
- DOI:
10.1038/npp.2008.156 - 发表时间:
2008-12-12 - 期刊:
- 影响因子:7.100
- 作者:
P Jeffrey Conn;Carrie K Jones - 通讯作者:
Carrie K Jones
Ethanol-Induced Adaptations to Inhibitory Microcircuits in the Mouse Prefrontal Cortex
- DOI:
10.1016/j.biopsych.2021.02.313 - 发表时间:
2021-05-01 - 期刊:
- 影响因子:
- 作者:
Max Joffe;Anthony Ferranti;Danny Winder;P Jeffrey Conn - 通讯作者:
P Jeffrey Conn
Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?
自闭症谱系障碍的药物治疗:新兴方法会产生新的治疗方法吗?
- DOI:
10.1038/npp.2015.259 - 发表时间:
2015-12-10 - 期刊:
- 影响因子:7.100
- 作者:
Rocco G Gogliotti;P Jeffrey Conn - 通讯作者:
P Jeffrey Conn
P Jeffrey Conn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('P Jeffrey Conn', 18)}}的其他基金
Discovery of mGlu receptor PAMs for treatment of schizophrenia
发现 mGlu 受体 PAM 用于治疗精神分裂症
- 批准号:
10531546 - 财政年份:2019
- 资助金额:
$ 13.87万 - 项目类别:
Discovery of mGlu receptor PAMs for treatment of schizophrenia
发现 mGlu 受体 PAM 用于治疗精神分裂症
- 批准号:
10305625 - 财政年份:2019
- 资助金额:
$ 13.87万 - 项目类别:
Novel mGlu5 negative allosteric modulators as first-in-class non-addictive analgesic therapeutics
新型 mGlu5 负变构调节剂作为一流的非成瘾镇痛疗法
- 批准号:
10450295 - 财政年份:2019
- 资助金额:
$ 13.87万 - 项目类别:
Discovery of mGlu receptor PAMs for treatment of schizophrenia
发现 mGlu 受体 PAM 用于治疗精神分裂症
- 批准号:
10063834 - 财政年份:2019
- 资助金额:
$ 13.87万 - 项目类别:
Novel mGlu5 Negative Allosteric Modulators as First-in-Class Non-Addictive Analgesic Therapeutics
新型 mGlu5 负变构调节剂作为一流的非成瘾性镇痛治疗药物
- 批准号:
10477066 - 财政年份:2019
- 资助金额:
$ 13.87万 - 项目类别:
Novel mGlu5 negative allosteric modulators as first-in-class non-addictive analgesic therapeutics
新型 mGlu5 负变构调节剂作为一流的非成瘾镇痛疗法
- 批准号:
10581793 - 财政年份:2019
- 资助金额:
$ 13.87万 - 项目类别:
Development of an M1 PAM experimental therapeutic for schizophrenia
开发治疗精神分裂症的 M1 PAM 实验疗法
- 批准号:
9140071 - 财政年份:2015
- 资助金额:
$ 13.87万 - 项目类别:
Development of mGIuR5 NAMS for Treatment of Major Depression
mGIuR5 NAMS 的开发用于治疗重度抑郁症
- 批准号:
8434427 - 财政年份:2013
- 资助金额:
$ 13.87万 - 项目类别:
Development of mGIuR5 NAMS for Treatment of Major Depression
用于治疗重度抑郁症的 mGIuR5 NAMS 的开发
- 批准号:
8603872 - 财政年份:2013
- 资助金额:
$ 13.87万 - 项目类别:
Discovery and Optimization of Selective Negative Allosteric Modulators of mGluR3
mGluR3 选择性负变构调节剂的发现和优化
- 批准号:
8726488 - 财政年份:2012
- 资助金额:
$ 13.87万 - 项目类别:
相似海外基金
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2022
- 资助金额:
$ 13.87万 - 项目类别:
Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2022
- 资助金额:
$ 13.87万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2021
- 资助金额:
$ 13.87万 - 项目类别:
Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2021
- 资助金额:
$ 13.87万 - 项目类别:
Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
- 批准号:
451966 - 财政年份:2021
- 资助金额:
$ 13.87万 - 项目类别:
Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10455587 - 财政年份:2020
- 资助金额:
$ 13.87万 - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10261394 - 财政年份:2020
- 资助金额:
$ 13.87万 - 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
- 批准号:
20K08498 - 财政年份:2020
- 资助金额:
$ 13.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
- 批准号:
10380126 - 财政年份:2020
- 资助金额:
$ 13.87万 - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10662279 - 财政年份:2020
- 资助金额:
$ 13.87万 - 项目类别:














{{item.name}}会员




